-
The Earth Auger Toilet: A Solution For The Masses?
Sub-Saharan Africa remains one of the primary regions with the least improvement in accomplishing the Millennium Development Goal (MDG) on sanitation by 2015, with only a 30% coverage and an increase of 4% since 1990. In most parts of the region, open defecation is an easier and cheaper alternative, as improved sanitation facilities, which ensure hygienic separation of human excreta from human contact, are either non-existent or too expensive.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- innovation, public health
-
‘Disease outbreak guarantees’—A proposed mechanism for enhancing public health capacity
The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.
- Categories
- Health Care
-
The Economics of Antibiotic Resistance
The business model for developing new antibiotics is broken, researchers say. The question is, can we make a new one that works?
- Categories
- Health Care
- Tags
- public health
-
‘There’s no point giving free cancer drugs to Africa’
Giving out free cancer drugs would not help the poorest parts of Africa, the head of pharmaceutical giant AstraZeneca has told the BBC.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
With Another Pandemic Looming, Let’s Change Perspective
We cannot prevent the emergence of new viruses, according to Dr. Melvin Sanicas, a Global Health Fellow and program officer at the Bill & Melinda Gates Foundation, but we can take measures to prevent small epidemics from becoming big ones, including investing in infrastructures for preparedness.
- Categories
- Health Care
-
Hepatitis C drugs remain unaffordable in many countries, says WHO study
In the latest effort to quantify the burden of expensive medicines, a new study found that the cost of two widely used hepatitis C treatments remains out of reach for people in many poor countries and poses a “financial and ethical dilemma” for payers and doctors. The study found that if a patient paid for treatment out of pocket, the cost of a full course of Sovaldi alone would equal one year or more of average earnings for people in 12 countries.
- Categories
- Health Care
- Tags
- public health
-
‘Clubfoot Can Be Solved on a Global Scale’
miraclefeet believes clubfoot can be solved on a global scale and envisions a world where every child can receive treatment. The five-year-old organization partners with local health care providers in public hospitals to support the Ponseti treatment and to ultimately create sustainable clubfoot programs in low-resource countries.
- Categories
- Health Care
-
India’s New Patent Policy Spurs Debate Over Implications for Pharma
Amid an ongoing rift with the US government, India last week issued a new policy about intellectual property, but opinions are divided over whether the move will appease the pharmaceutical industry, which has been pushing the Indian government to strengthen patent protection.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health